Intermediates-copy

Product

Homepage

Intermediates-copy

Intermediates

(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol

(1S,2S,3R,5S)-(+)-2,3-Pinanediol

(2R, 3S)-2-[(1R)-l-[3, 5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine,4-methylbenzenesulfonate

(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol

(R)-(+)-1-(1-Naphthyl)ethanol

(R)-(+)-1-(1-Naphthyl)ethylamine

(R)-(+)-1-Phenylethanol

【Alias】L-Phenylethanol; (R)-(+)-1-Phenylyl alcohol; R-(+)-sec-phenylethanol
【Catalog Number】CR8011
【CAS #】1517-69-7
【Molecular Formula】 C8H10O
【Molecular Weight】122.16

(R)-(3-Chlorophenyl)oxirane

(R)-(4-Fluorophenyl)oxirane

(R)-1-(4-Bromophenyl)ethanol

(R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol Hydrochloride

(R)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-benzylmorpholin-3-one

(R)-2-(1-Hydroxyethyl)pyridine

(R)-2-(4-Chlorophenyl)oxirane

(R)-4-(1-Hydroxyethyl)pyridine

(S)-(-)-1-(1-Naphthyl)ethanol

(S)-(-)-1-Phenylethanol

【Alias】D-1-phenylethanol; (S)-(-)-1-phenylethanol
【Catalog Number】CR8010
【CAS #】1445-91-6
【Molecular Formula】C8H10O
【Molecular Weight】122.16

(S)-(-)-Styrene Oxide

(S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile

(S)-1-(4-Bromophenyl)ethanol

News Center

Viwit’s Levetiracetam Tablets Approved by FDA 2024-04-09 11:28:41

On April 5, 2024, Viwit Pharmaceuticals' Levetiracetam Tablets received an Approval Letter (#078869) from the U.S. Food and Drug Administration (FDA), marking Viwit's first approved oral solid dosage in the United States.

Viwit Pharmaceuticals' Mirabegron API Receives Official Approval by China NMPA 2024-01-26 11:09:29

On January 23, 2024, Viwit Pharmaceuticals received the "Notice of Approval of Application for Listing of Chemical APIs" issued by China National Medical Products Administration (NMPA) for its own proprietary active pharmaceutical ingredient (API) Mirabegron, developed independently. The issued registration number is Y20220000096, and the corresponding notice number is 2024YS00039.

Viwit Pharmaceuticals' Vildagliptin Tablets Receive Official Approval by China NMPA 2023-12-22 13:19:44

Viwit Pharmaceuticals is pleased to announce the acquisition of the Drug Registration Certificate (Certificate No: 2023S01974) from the National Medical Products Administration (NMPA) for a proprietary finished dosage form, Vildagliptin tablet. This signifies the official approval of this product in the Chinese market.

Viwit Pharmaceuticals' Lidocaine Injection Receives Official Approval by China NMPA 2023-12-19 11:25:05

On December 18, 2023, Viwit Pharmaceuticals received the "Drug Supplementary Application Approval Notice" (Notice No: 2023B06224) issued by the China National Medical Products Administration for a proprietary finished dosage form, Lidocaine Hydrochloride for Injection (5ml: 0.1g).

Viwit Pharmaceuticals' Vildagliptin API Receives Official Approval by China NMPA 2023-12-07 08:31:28

On November 30, 2023, Viwit Pharmaceuticals received the "Notice of Approval of Application for Listing of Chemical APIs" issued by National Medical Products Administration (NMPA) for its independently developed active pharmaceutical ingredient (API), Vildagliptin. The registration number is Y20210000619, and the notice number is 2023YS00803.

Viwit Pharmaceuticals' Aprepitant API Receives Official Approval by China NMPA 2023-10-31 15:33:57

On October 26, 2023, Viwit Pharmaceuticals received the "Notice of Approval of Application for Listing of Chemical APIs" issued by China National Medical Products Administration (NMPA) for the independently developed active pharmaceutical ingredient (API) Aprepitant. The registration number is Y20210000473, and the notice number is 2023YS00727.

Intermediates-copy

Categories:Intermediates
Time of issue:2023-05-05 10:44:20
Views:0

Description:

Information

No.	API	KSM/Interm	Structure	CAS	Chemical Name	US DMF
1	Varenicline Tartrate	Interm		230615-70-0	2,2,2 - trifluoro - 1 - (6,7,9,10-tetrahydro- 8H - 6,10 -methanoazepino [4,5-g]quinoxaline- 8 - yl) ethan - 1 - one	Tech Pack
2	Aprepitant	KSM		287930-73-8	4-Benzyl-2-hydroxy-morpholin-3-one	Tech Pack
		KSM		127852-28-2	(1R)-1-[3,5-Bis(trifluoromethyl) phenyl]ethanol	Tech Pack
		Interm		287930-75-0	(R)-2-((R)-1-(3,5-bis (trifluoromethyl)phenyl) ethoxy)-4-benzylmorpholin-3-one	Tech Pack
		Interm		200000-59-5	(2R, 3S)-2-[(1R)-l-[3, 5-Bis (trifluoromethyl)phenyl] ethoxy]-3-(4-fluorophenyl) morpholine, 4- methylbenzenesulfonate	√
		Interm		155742-64-6	N-Methylcarbonyl-2-chloroacetamidrazone	Tech Pack
		Interm		252742-72-6	5-Chloromethyl-2,4-Dithydro-[1,2,4]Triazol-3-One	Tech Pack
3	Fosaprepitant Dimeglumine	Interm		990-91-0	Tetrabenzyl pyrophosphate	Tech Pack
3	Fosaprepitant Dimeglumine	Interm		265121-01-5	Dibenzyl (3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonate	Tech Pack
4	Vildagliptin	Interm		207557-35-5	(S)-1-(2-chloroacetyl)pyrrolidine-2- carbonitrile	Tech Pack
4	Vildagliptin	Interm		702-82-9	3-Amino-1-hydroxyadamantane	Tech Pack
5	Efinaconazole	Interm		144230-50-2	4-Methylidenepiperidine, hydrochloride	Tech Pack
		Interm		133775-25-4	(2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol	√
		Interm		127000-90-2	1-(((2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole	√
6	Gadoterate Meglumine	Interm		60239-18-1	1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid	Tech Pack
7	Mirabegron	Interm		20780-53-4	(R)-Styrene oxide	Tech Pack
8	Luliconazole	Interm		98873-55-3	Imidazole-1-yl-acetonitrile	Tech Pack
8	Luliconazole	Interm		126534-31-4	(S)-2-chloro-1-(2,4-dich lorophenyl) ethanol	Tech Pack
9	Atazanavir Sulfate	Interm		198904-86-8	2-[(2S,3S)-3-[[(1,1-Dimethylethoxy) carbonyl]amino]-2-hydroxy-4-phenyl-butyl]-2-[[4-(2-pyridinyl)phenyl] methyl] hydrazinecarboxylic acid, 1,1-dimethylethyl ester	Tech Pack
10	Bortezomib	Interm		179324-87-9	(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate	Tech Pack
		Interm		114457-94-2	N-(2-Pyrazinylcarbonyl)-L-phenylalanine	Tech Pack
		Interm		205393-22-2	Bortezomib pinanediol ester	Tech Pack
11	Brinzolamide	Interm		160982-16-1	(S)-3,4-Dihydro-6-chloro-4-hydroxy-4H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide	Tech Pack
12	Rivaroxaban	Interm		446292-08-6	2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl] methyl]-1H-isoindole-1,3(2H)-dione	Tech Pack
12	Rivaroxaban	Interm		446292-07-5	2-[(2R)-2-Hydroxy-3-[[4-(3-oxo-4-morpholinyl)-phenyl]amino]propyl]-1H-isoindole-1,3(2H)-dione	Tech Pack
13	Cinacalcet	Interm		1005450-55-4	N-((R)-1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)-propanamide	Tech Pack
13	Cinacalcet	Interm		585-50-2	3-(3-Trifluoromethylphenyl)propionic acid	Tech Pack
14	Eletriptan	Interm		143322-57-0	(R)-5-Bromo-3-((1-methylpyrrolidin-2-yl)methyl)-1H-indole	Tech Pack
15	Indacaterol	Interm		312753-53-0	5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride	Tech Pack
15	Indacaterol	Interm		173140-90-4	5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone	Tech Pack
16	Sitagliptin	Interm		764667-65-4	(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]-pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one	Tech Pack
17	Fosamprenavir calcium	Interm		160232-08-6	([1S,2R]-(1-Benzyl-2-hydroxy-3-(isobutyl-amino)-propyl)carbamic acid tert-butylester	Tech Pack
18		KSM		878376-35-3	Pyridine-2-sulfonyl fluoride	Tech Pack
19		KSM		473923-95-4	3-Fluoro-5-hydroxybenzonitrile	Tech Pack

Scan the QR code to read on your phone



Confirm

About Us

R&D and Innovation

Products

Innovation

Sustainable

News Center

Join Us

News Center

VIWIT 沪ICP备12014533号-2 Terms of Use

中文